Download PDF
1
/
Pages
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Analysis of the prescription process of PCSK9 inhibitors in the cardiology departments of Spanish hospitals and optimization proposal. The IKIGAI study
Vivencio Barrios; Carlos Escobar; Vicente Arrarte; Marisol Bravo; Alfredo del Campo; Rafael Hidalgo; Lluís Recasens; Ángel Cequier;
Clin Investig Arterioscler. 2021;33:296-305
Long-term treatment persistence and maintained reduction of LDL-cholesterol levels with evolocumab over 30 months: Results from the Spanish cohort of the European prospective HEYMANS study
Agustín Blanco Echevarría; Juan De Dios García Díaz; Assumpta Caixas; Núria Plana Gil; Miguel Ángel Rico Corral; Ian Bridges; Nafeesa Dhalwani; Sònia Gatell Menchen; Kausik K. Ray;
Clin Investig Arterioscler. 2023;35:263-71
Multizonal observational study conducted by clinical practitioners on Repatha® use in patients with hyperlipidemia (ZERBINI): Colombian results
Heidy M. Roncancio; Julián R. Lugo-Peña; Ángel A. García; Janeth Leal; Carlos A. Hoyos; Johnny A. Beltrán; César L. Cruz; Carol Paez-Cano; Mariana Pineda-Posada; Eduardo Contreras;
Clin Investig Arterioscler. 2024;36:22-32